Multimodal visibility (radiography, computed tomography, and magnetic resonance imaging) of microspheres for transarterial embolization tested in porcine kidneys

• Verfasst von: Sommer, Christof-Matthias [VerfasserIn]
• Verfasst von: Stampfl, Ulrike [VerfasserIn]
• Verfasst von: Bellemann, Nadine [VerfasserIn]
• Verfasst von: Holzschuh, Maria [VerfasserIn]
• Verfasst von: Kueller, Alexander [VerfasserIn]
• Verfasst von: Bluemmel, Jaques [VerfasserIn]
• Verfasst von: Gehrig, Tobias [VerfasserIn]
• Verfasst von: Shevchenko, Maxym [VerfasserIn]
• Verfasst von: Kenngott, Hannes Götz [VerfasserIn]
• Verfasst von: Kauczor, Hans-Ulrich [VerfasserIn]
• Verfasst von: Pereira, Philippe L. [VerfasserIn]
• Verfasst von: Radeleff, Boris [VerfasserIn]
• Titel: Multimodal visibility (radiography, computed tomography, and magnetic resonance imaging) of microspheres for transarterial embolization tested in porcine kidneys
• Verf.angabe: Christof M. Sommer, Ulrike Stampfl, Nadine Bellemann, Maria Holzschuh, Alexander Kueller, Jaques Bluemmel, Tobias Gehrig, Maxym Shevchenko, Hannes G. Kenngott, Hans U. Kauczor, Philippe L. Pereira, and Boris A. Radeleff
• Jahr: 2013
• Umfang: 10 S.
• Fussnoten: Gesehen am 10.02.2022
• Titel Quelle: Enthalten in: Investigative radiology
• Ort Quelle: Philadelphia, Pa. : Lippincott Williams & Wilkins, 1966
• Jahr Quelle: 2013
• Band/Heft Quelle: 48(2013), 4 vom: Apr., Seite 213-222
• ISSN Quelle: 1536-0210
• DOI: doi:10.1097/RLI.0b013e31827f6598
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1789212065

Abstract

Objective - The objective of this study was to test multimodal visibility (radiography, computed tomography [CT], and magnetic resonance imaging [MRI]) of microspheres for transarterial embolization in porcine kidneys. - Materials and Methods - Currently available embolization particles (microspheres) were modified. A dense x-ray material (barium sulfate) was added to create visibility for radiography and CT. A magnetic substance (iron oxide) was additionally added to create visibility for MRI. This chemical modification was performed for particles with sizes of 100 ± 25 and 700 ± 50 μm. Three different prototypes per size class (samples A, B, and C) resulted, each with a different degree of barium sulfate but with the same degree of iron oxide. The currently available embolization particles with sizes of 100 ± 25 and 700 ± 50 μm were used as controls (sample control). Eight renal arteries of 4 pigs were embolized. Study end points were size distribution evaluated in vitro as well as qualitative and quantitative particle visibility evaluated in vivo. - Results - The size distribution of the particles with a size of 100 ± 25 μm was between 96 ± 11 μm for sample A and 102 ± 13 μm for the sample control without significant differences (n.s.). The size distribution of the particles with a size of 700 ± 50 μm was between 691 ± 20 μm for sample A and 716 ± 34 μm for sample C without significant differences (n.s.). For radiography, the particles with sizes of 100 ± 25 and 700 ± 50 μm for samples A, B, and C were definitely visible during the embolization. The sample control was definitely not visible. For CT and MRI (T1-weighted [T1w] and T2-weighted [T2w]), the particles with sizes of 100 ± 25 and 700 ± 50 μm for samples A, B, and C were definitely visible after the embolization. The sample control was definitely not visible. For CT, the signal-to-noise ratio for samples A, B, and C increased significantly after the embolization (eg, sample A, particles with a size of 100 ± 25 μm: 66.5% ± 23.7%, P < 0.05). The signal-to-noise ratio for the sample control did not change after the embolization (eg, sample control, particles with a size of 700 ± 25 μm: −0.2% ± 15.2%, n.s.). For MRI (T1w and T2w), the signal-to-noise ratio for samples A, B, and C decreased significantly after the embolization (eg, sample B, particles with a size of 700 ± 50 μm, T1w: −72.9% ± 6.6%; P < 0.05). The signal-to-noise ratio for the sample control did not change after the embolization (eg, sample control, particles with a size of 100 ± 25 μm, T2w: 6.2% ± 16.1%, n.s.). - Conclusions - In this study, the chemical modification of the currently available microspheres for transarterial embolization resulted in a size distribution comparable with the currently available microspheres and created multimodal visibility for radiography, CT, and MRI.